Stephens Consulting’s Recursion Pharmaceuticals RXRX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$340 Sell
67
-120
-64% -$609 ﹤0.01% 992
2025
Q1
$990 Buy
187
+120
+179% +$635 ﹤0.01% 647
2024
Q4
$453 Buy
+67
New +$453 ﹤0.01% 500